Assert-IQ vs Study Watch with Irregular Pulse Monitor (Home)

Assert-IQ, once minimally invasively inserted, provides up to six years of continuous, passive monitoring for the patient, requiring little to no daily interaction beyond optional symptom logging. In contrast, the Study Watch, as a wearable, necessitates continuous wearing and weekly charging, which can be a higher ongoing burden for the patient.

Assert-IQ offers long-term continuous cardiac monitoring for up to six years with advanced arrhythmia detection algorithms and proactive clinician alerts, providing comprehensive diagnostic and management capabilities for suspected heart rhythm disorders. While the Study Watch provides irregular pulse monitoring and on-demand ECG, its capabilities are more geared towards screening and episodic assessment rather than the extensive, continuous data collection of an ICM.

Both tools lack public pricing details, requiring direct contact for institutional pricing, making a direct cost comparison impossible. While Assert-IQ (an ICM) likely involves higher initial costs due to the device and implantation procedure, its value proposition of six years of continuous monitoring differs significantly from the wearable Study Watch. Without specific pricing, it's impossible to determine which offers better value.

Assert-IQ, from Abbott Medical, is explicitly targeted at large health systems and hospitals, is FDA cleared, and fully HIPAA compliant. Verily's Study Watch also has FDA clearance and states HIPAA compliance, but a reported lawsuit alleging HIPAA breaches in past operations could raise concerns for enterprise trust and adoption. Abbott's long-standing presence and established infrastructure in the medical device industry provide a stronger foundation for enterprise integration and trust.

While Assert-IQ offers impressive longevity and advanced algorithms for an insertable cardiac monitor, the Study Watch demonstrates greater innovation by integrating a wider array of physiological (ECG, heart rate, electrodermal activity, inertial movements) and environmental sensors into a wearable device. This multi-modal sensing, combined with cloud-based proprietary algorithms and machine learning, pushes the boundaries of remote data collection and analysis in a wearable format for clinical research and healthcare use.

Abbott, as a well-established global medical device company, has a robust and mature infrastructure for providing comprehensive support, training, and extensive documentation for healthcare professionals using its products like Assert-IQ. Verily's Study Watch, while backed by a large tech company, is primarily positioned for clinical research and prescription use, suggesting a support structure that may be more tailored to specific research institutions or prescribing entities rather than a broad clinical audience.